A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery
Primary Purpose
Cataract
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
GALILEI G6 Lens Professional
Oculus Pentacam AXL
Sponsored by
About this trial
This is an interventional diagnostic trial for Cataract
Eligibility Criteria
Inclusion Criteria:
Satisfies one of the subject group categories and the enrollment quota for that category has not been reached:
- Normal eyes (phakic eyes without cataracts or corneal disease, refraction ≥ -5.5 D or ≤ +5.0 D)
- Eyes having undergone previous refractive surgery (LASIK or PRK)
- Eyes with cataracts (LOCS III grading with grades 2-6 in any or all of the posterior subcapsular (P2-P5), nuclear (N2-N5) and cortical (C2-C5), assessed by slit lamp examination; no other known ocular pathology)
- Eyes with severe myopia (≤ -6 D according to the American Academy of Ophthalmology)
- Eyes with severe hyperopia (≥ +5.25 D according to the American Academy of Ophthalmology)
- Eyes with previous cross-linking and eyes with advanced keratoconus
- Manifest refraction sSpherical eEquivalent Refraction (MRSER) between -10dpt and +10dpt as measured by cycloplegic autorefraction assessed less than 12 months prior to enrollment
- Best corrected visual acuity (BCVA) of LogMAR 0.2 or better
Exclusion Criteria:
- Strabismus, nystagmus, amblyopia, anisometropia (difference in MRSER>3D)
- Angle closure glaucoma
- Seizure disorder, brain damage, Down Syndrome, Trisomy 13 or 18, Cerebral Palsy or other serious ophthalmic or central nervous system disorders
- Severe dry eye
- Severe corneal scarring
- Inability to hold gaze
- Inability to see fixation target
Sites / Locations
- Ziemer Ophthalmic Systems AG
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
GALILEI G6 Lens Professional
Oculus Pentacam AXL
Arm Description
The GALILEI G6 Lens Professional will measure anterior segment geometry and axial intra-ocular distances of the eye.
The Oculus Pentacam AXL will measure anterior segment geometry and axial intra-ocular distances of the eye.
Outcomes
Primary Outcome Measures
Axial Length (AL) Measurement in millimeters (mm)
Repeatability and reproducability across and between evaluations
Central Corneal Thickness (CCT) Measurement in micrometers (µm)
Repeatability and reproducability across and between evaluations
Radius Flat Meridian (R flat) Measurement in millimeters (mm)
Repeatability and reproducability across and between evaluations
Radius Steep Meridian (R steep) Measurement in millimeters (mm)
Repeatability and reproducability across and between evaluations
Mean Radius (Rm) Measurement in millimeters (mm)
Repeatability and reproducability across and between evaluations
Corneal Cylinder Measurement in diopters (D)
Repeatability and reproducability across and between evaluations
Corneal Cylinder Axis (A flat) Measurement in degrees
Repeatability and reproducability across and between evaluations
Anterior Chamber Depth (ACD) Measurement in millimeters (mm)
Repeatability and reproducability across and between evaluations
Horizontal White-to-White distance (WtW) Measurement in millimeters (mm).
Repeatability and reproducability across and between evaluations
Secondary Outcome Measures
Full Information
NCT ID
NCT03396003
First Posted
November 20, 2017
Last Updated
September 24, 2018
Sponsor
Ziemer Ophthalmic Systems AG
1. Study Identification
Unique Protocol Identification Number
NCT03396003
Brief Title
A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery
Official Title
GALILEI G6 Lens Professional vs. a Predicate Device: a Comparison Study
Study Type
Interventional
2. Study Status
Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
January 5, 2018 (Actual)
Primary Completion Date
August 1, 2018 (Actual)
Study Completion Date
August 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ziemer Ophthalmic Systems AG
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare the Ziemer Ophthalmic Systems AG GALILEI G6 Lens Professional to the Oculus Pentacam® AXL for taking images and measurements of the anterior segment of the eye, including the cornea, pupil, anterior chamber and lens, to assist in determining the power of the intraocular lens for implantation.
Detailed Description
A corneal topographer/biometer named GALILEI G6 Lens Professional was developed by Ziemer Ophthalmic Systems AG for the measurement of anterior segment geometry and axial intraocular distances. The measurement principle of the corneal topographer corresponds to that of the commercially available Galilei G4 Dual Scheimpflug Analyzer, whereas the measurement principle of the biometer is based on low coherence interferometry/reflectometry, which has been widely used and applied clinically by a number of predicate devices.
One complete measurement consists of a corneal topography/ tomography scan followed by three consecutive, axial biometry scans of the anterior segment (cornea and crystalline lens) and three consecutive, axial biometry scans of the retina. The measurement process is continuous but divided into three alignment-click-steps.
Such measurements can be applied to given Intra Ocular Lens (IOL) types and IOL equations, to permit the calculation of recommended IOLs to be implanted during cataract surgery in order to achieve the desired vision correction.
The primary objectives of this clinical study are to: 1) evaluate the inter-device repeatability, inter-operator repeatability and reproducibility of the GALILEI G6 Lens Professional in repeated measurements of anterior segment geometry and axial intraocular distances and, 2) demonstrate substantial equivalence through examining agreement of the GALILEI measurements to those of the predicate device, the Pentacam® AXL.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
112 (Actual)
8. Arms, Groups, and Interventions
Arm Title
GALILEI G6 Lens Professional
Arm Type
Experimental
Arm Description
The GALILEI G6 Lens Professional will measure anterior segment geometry and axial intra-ocular distances of the eye.
Arm Title
Oculus Pentacam AXL
Arm Type
Active Comparator
Arm Description
The Oculus Pentacam AXL will measure anterior segment geometry and axial intra-ocular distances of the eye.
Intervention Type
Device
Intervention Name(s)
GALILEI G6 Lens Professional
Intervention Description
Eight measurements of the eye using the GALILEI G6 Lens Professional will be taken using two different devices and 2 different operators
Intervention Type
Device
Intervention Name(s)
Oculus Pentacam AXL
Intervention Description
A single measurement of the eye will be taken using the Oculus Pentacam AXL
Primary Outcome Measure Information:
Title
Axial Length (AL) Measurement in millimeters (mm)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Central Corneal Thickness (CCT) Measurement in micrometers (µm)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Radius Flat Meridian (R flat) Measurement in millimeters (mm)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Radius Steep Meridian (R steep) Measurement in millimeters (mm)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Mean Radius (Rm) Measurement in millimeters (mm)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Corneal Cylinder Measurement in diopters (D)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Corneal Cylinder Axis (A flat) Measurement in degrees
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Anterior Chamber Depth (ACD) Measurement in millimeters (mm)
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
Title
Horizontal White-to-White distance (WtW) Measurement in millimeters (mm).
Description
Repeatability and reproducability across and between evaluations
Time Frame
One day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Satisfies one of the subject group categories and the enrollment quota for that category has not been reached:
Normal eyes (phakic eyes without cataracts or corneal disease, refraction ≥ -5.5 D or ≤ +5.0 D)
Eyes having undergone previous refractive surgery (LASIK or PRK)
Eyes with cataracts (LOCS III grading with grades 2-6 in any or all of the posterior subcapsular (P2-P5), nuclear (N2-N5) and cortical (C2-C5), assessed by slit lamp examination; no other known ocular pathology)
Eyes with severe myopia (≤ -6 D according to the American Academy of Ophthalmology)
Eyes with severe hyperopia (≥ +5.25 D according to the American Academy of Ophthalmology)
Eyes with previous cross-linking and eyes with advanced keratoconus
Manifest refraction sSpherical eEquivalent Refraction (MRSER) between -10dpt and +10dpt as measured by cycloplegic autorefraction assessed less than 12 months prior to enrollment
Best corrected visual acuity (BCVA) of LogMAR 0.2 or better
Exclusion Criteria:
Strabismus, nystagmus, amblyopia, anisometropia (difference in MRSER>3D)
Angle closure glaucoma
Seizure disorder, brain damage, Down Syndrome, Trisomy 13 or 18, Cerebral Palsy or other serious ophthalmic or central nervous system disorders
Severe dry eye
Severe corneal scarring
Inability to hold gaze
Inability to see fixation target
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Majid Moshirfar, MD
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ziemer Ophthalmic Systems AG
City
Port
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery
We'll reach out to this number within 24 hrs